tert-Butyl 3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 97%, 1g

N-a-Boc-N-e-allyloxycarbonyl-L-lysine dicyclohexylaminesalt, 95.0%, 25g

Phenylmagnesium bromide 1.0 M in Tetrahydrofuran, 100ml

ethyl 2-hydroxy-4-(naphthalen-2-yl)-4-oxobut-2-enoate, 95%, 250mg

2,2-Dimethylpentane>99.0%(GC)5mL

3-(Hydroxymethyl)-1-adamantanol>98.0%(GC)5g

2,4,6-Trichlorobenzoic Acid>98.0%(GC)(T)25g

Dibenzocyclooctyne-amine>95.0%(HPLC)25mg

Plan PLMi 20x/0.40 infinity corrected IOS objective. Working distance 8.8 mm

(E)-3-(Dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride (Doxepin Impurity), 97%, 50mg

(S)-4-Carbamoyl-3-(9H-fluoren-9-ylmethoxycarbonyl-amino)-butyric acid, 95.0%, 100mg

HEPES, 100 g

(prop-2-en-1-yl)[(3,4,5-trimethoxyphenyl)methyl]amine, 95.0%, 10g